Role of adjuvant therapy de-escalation for low-grade endometrioid endometrial cancer with adnexal only metastasis: call for research
- 2 March 2026
- journal article
- review article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (3) , 102832
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Low-grade endometrioid endometrial cancer with adnexal only metastasis: Evaluation of de-escalation of adjuvant therapyEuropean Journal of Cancer, 2024
- Validation of the 2023 FIGO staging schema for advanced endometrial cancerEuropean Journal of Cancer, 2023
- FIGO staging of endometrial cancer: 2023International Journal of Gynecology & Obstetrics, 2023
- Annual report to the nation on the status of cancer, part 1: National cancer statisticsCancer, 2022
- ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinomaVirchows Archiv, 2021
- Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomasThe Journal of Pathology, 2019
- The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomasArchives of Gynecology and Obstetrics, 2019
- Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinomaBrachytherapy, 2018
- Sexual Functioning Among Endometrial Cancer Patients Treated With Adjuvant High-Dose-Rate Intra-Vaginal Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm dataEuropean Journal of Cancer, 2012